↓ Skip to main content

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
98 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd002130.pub4
Pubmed ID
Authors

Bosch X, Marrugat J, Sanchis J

Abstract

During percutaneous coronary intervention (PCI), and in non-ST segment elevation acute coronary syndromes (NSTEACS), the risk of acute vessel occlusion by thrombosis is high. Glycoprotein IIb/IIIa blockers strongly inhibit platelet aggregation and may prevent mortality and myocardial infarction. This is an update of a Cochrane review first published in 2001, and previously updated in 2007 and 2010.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
United States 2 2%
Denmark 1 1%
Brazil 1 1%
Colombia 1 1%
Unknown 91 93%

Demographic breakdown

Readers by professional status Count As %
Unspecified 21 21%
Student > Master 20 20%
Researcher 11 11%
Student > Bachelor 10 10%
Student > Ph. D. Student 9 9%
Other 27 28%
Readers by discipline Count As %
Medicine and Dentistry 54 55%
Unspecified 22 22%
Social Sciences 6 6%
Psychology 4 4%
Nursing and Health Professions 4 4%
Other 8 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 October 2017.
All research outputs
#7,785,519
of 13,516,340 outputs
Outputs from Cochrane database of systematic reviews
#8,465
of 10,622 outputs
Outputs of similar age
#107,518
of 243,550 outputs
Outputs of similar age from Cochrane database of systematic reviews
#147
of 177 outputs
Altmetric has tracked 13,516,340 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 10,622 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.